Open access
Sep 2026
CD28-ICOS costimulation enhances the therapeutic efficacy of L1CAM-targeted CAR-T cells against ovarian and gastric cancers
The combination of rational CAR design (CD28-ICOS signaling) and optimized delivery strategy provides a strong rationale for the clinical development of L1CAM-targeted CAR-T therapy, particularly in patients with L1CAM-positive solid tumors.
X. Che, Un-Jung Yun, Junsub Lee et al.
· Journal for ImmunoTherapy of... · 0 citations